Advertisement
U.S. markets closed

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
57.50+0.75 (+1.32%)
At close: 04:00PM EST
57.50 0.00 (0.00%)
After hours: 04:13PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
742
11,580
35,380
29,390
42,983
Operating Expense
653,939
498,765
293,659
217,398
153,680
Operating Income
-653,197
-487,185
-258,279
-188,008
-110,697
Net Non Operating Interest Income Expense
84,332
47,179
9,154
917
2,167
Other Income Expense
-
115
-
-
-
Pretax Income
-566,718
-439,891
-249,125
-187,091
-108,530
Tax Provision
343
-3,524
-420
0
-371
Net Income Common Stockholders
-567,061
-436,367
-248,705
-187,091
-110,378
Diluted NI Available to Com Stockholders
-567,061
-436,367
-248,705
-187,091
-110,378
Basic EPS
-3.26
-3.86
-3.08
-2.57
-2.01
Diluted EPS
-3.26
-3.86
-3.08
-2.57
-2.01
Basic Average Shares
100,090
113,150
80,627
72,806
54,874
Diluted Average Shares
100,090
113,150
80,627
72,806
54,874
Total Operating Income as Reported
-653,197
-487,185
-258,279
-188,008
-110,697
Total Expenses
653,939
498,765
293,659
217,398
153,680
Net Income from Continuing & Discontinued Operation
-567,061
-436,367
-248,705
-187,091
-108,159
Normalized Income
-570,650
-436,367
-248,705
-187,091
-108,159
Interest Income
84,635
47,482
9,154
929
2,238
Interest Expense
-
303
0
12
71
Net Interest Income
84,332
47,179
9,154
917
2,167
EBIT
-605,600
-439,588
-249,125
-187,079
-108,459
EBITDA
-594,305
-430,279
-239,469
-179,747
-101,914
Reconciled Depreciation
11,295
9,309
9,656
7,332
6,545
Net Income from Continuing Operation Net Minority Interest
-567,061
-436,367
-248,705
-187,091
-108,159
Total Unusual Items Excluding Goodwill
4,543
-
-
-
-
Total Unusual Items
4,543
-
-
-
-
Normalized EBITDA
-598,848
-430,279
-239,469
-179,747
-101,914
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
954.03
0
0
0
0